Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Con argument.
Fellermann
Klaus
K
Department of Internal Medicine I, Robert-Bosch-Krankenhaus, Stuttgart, Germany. klaus.fellermann@rbk.de
Lühmann
Dagmar
D
Stange
Eduard F
EF
D016572:Cyclosporine / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D015201:Meta-Analysis as Topic
D007166:Immunosuppressive Agents; D016572:Cyclosporine